Call for applications for a fully financed PhD fellowship
The research project for the position falls within the topic of radiobiology, and will be supervised by Professor Brita Singers Sørensen. The project is funded by the Danish Cancer Society.
Re-irradiation, a second course of radiotherapy in a previously treated area, is increasingly used as more cancer patients survive their first treatment. However, re-irradiation carries a high risk of severe side effects in the healthy tissue. Clinical decisions are limited by a lack of biological knowledge about how much healthy tissue can tolerate a second time, and how much it recovers between treatment courses. Proton therapy is promising for re-irradiation because it spares more of the surrounding healthy tissue, but its biological effect in this setting has never been investigated systematically.
The aim of the project is to supply preclinical data on how healthy tissue tolerance and recovery after re-irradiation depend on radiation type, fractionation and the varying biological effect of protons. This will be tested in a well-established mouse model, where both acute and late damage to healthy tissue can be measured in the same animals. The mice will first be irradiated with photons and then re-irradiated with either photons or protons, with different recovery intervals and fractionation schedules. The results will provide a biological basis for safer clinical use of re-irradiation and proton therapy. Read more about the project here: www.cancer.dk/forskning/forskning-vi-stoetter/det-gaar-pengene-til/sikrere-gentagen-straalebehandling/
The project is based at the Danish Centre for Particle Therapy (DCPT) and at the Department of Experimental Clinical Oncology, Aarhus University Hospital.
The project will take place in the experimental particle radiobiology research group of Professor Brita Singers Sørensen at Aarhus University. The research group is embedded in the joint oncology research environment at Aarhus University Hospital, at the Danish Centre for Particle Therapy and the Department of Experimental Clinical Oncology. The research environment is well-established and of high international standard, with research activities in radiation oncology bridging translational and clinical research. More than 30 PhD students and postdocs and more than 10 senior full-time researchers work in this environment.
We welcome applicants with a background in medicine, biology, molecular biology, biotechnology, biomedical engineering or similar. Prior experience with radiotherapy, radiobiology or physics is not required, as training will be provided.
The applicant must have:
A master’s degree or equivalent in one of the fields above
A strong interest in hands-on experimental work with laboratory animals
Fluency in English (oral and written)
Good planning skills, attention to detail and the ability to work independently
The ability to work in an interdisciplinary team with physicists, physicians and technicians
Willingness to work outside normal working hours when experiments require it
It will be a clear advantage to have at least one of the following:
Experience with laboratory mice, including a completed laboratory animal science course
Clinical competences, e.g. as a medical doctor or with clinical experience in oncology
Experience with data analysis or statistics (e.g. R or Python) is also an advantage.
Please submit your application via this link. Application deadline is 10 December 2026 at 23:59 Danish local trime. Preferred starting date is 1 February 2027.
For information about application requirements and mandatory attachments, please see our application guide.
Please contact Professor Brita Singers Sørensen, bsin@oncology.au.dk, for more information.
All interested candidates are encouraged to apply, regardless of their personal background. Salary and terms of employment are in accordance with applicable collective agreement.